Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria.
Hide M, Park HS, Igarashi A, Ye YM, Kim TB, Yagami A, Roh J, Lee JH, Chinuki Y, Youn SW, Lee SK, Inomata N, Choi JH, Fukunaga A, Wang J, Matsushima S, Greenberg S, Khalil S.
Hide M, et al. Among authors: lee sk, lee jh.
J Dermatol Sci. 2017 Jul;87(1):70-78. doi: 10.1016/j.jdermsci.2017.03.009. Epub 2017 Mar 21.
J Dermatol Sci. 2017.
PMID: 28366435
Free article.
Clinical Trial.